![STING/TBK1 Regulates Inflammation in Macrophages and Titanium Particles-Induced Osteolysis | ACS Biomaterials Science & Engineering STING/TBK1 Regulates Inflammation in Macrophages and Titanium Particles-Induced Osteolysis | ACS Biomaterials Science & Engineering](https://pubs.acs.org/cms/10.1021/acsbiomaterials.2c01509/asset/images/medium/ab2c01509_0009.gif)
STING/TBK1 Regulates Inflammation in Macrophages and Titanium Particles-Induced Osteolysis | ACS Biomaterials Science & Engineering
Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury | ACS Nano
![TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma | Nature Communications TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33137-8/MediaObjects/41467_2022_33137_Fig1_HTML.png)
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma | Nature Communications
![Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies | Signal Transduction and Targeted Therapy Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-023-01439-y/MediaObjects/41392_2023_1439_Fig1_HTML.png)